To determine the relative effect of multiple prognostic variables on overall post-recurrence survival time among cohorts of patients with recurrent ovarian cancer undergoing cytoreductive surgery. The mean weighted median disease-free interval prior to cytoreductive surgery was 20.2 months, and the mean weighted median overall post-recurrence survival time was 30.3 months. The weighted mean proportion of patients in each cohort undergoing consummate cytoreductive surgery was 52.2%. Median survival amended with incrementing year of publication (p = 0.009); however, the only statistically paramount clinical variable independently associated with post-recurrence survival time was the proportion of patients undergoing consummate cytoreductive surgery (p = 0.019). After controlling for all other factors, each 10% increase in the proportion of patients undergoing consummate cytoreductive surgery was associated with a 3.0 month increase in median cohort survival time. Among patients undergoing operative intervention for recurrent ovarian cancer, the proportion of patients undergoing consummate cytoreductive surgery is independently associated with overall post-recurrence survival time. The international journals are among the best open access journals in the world, set out to publish the most comprehensive, relevant and reliable information based on the current research and development on a variety of subjects. This information can be published in our peer reviewed journal with impact factors and are calculated using citations not only from research articles but also review articles (which tend to receive more citations), editorials, letters, meeting abstracts, short communications, and case reports.